The Nasdaq Stock Market might be America’s second-largest stock exchange, behind only the 234-year-old New York Stock Exchange. But it’s increasingly becoming the exchange of choice for Wall Street’s best stocks.
Just take a quick glance at the S&P 500. The eight largest holdings are listed on the Nasdaq. Among them are Nvidia (NVDA), Apple (AAPL) and Microsoft (MSFT), a murderer’s row of multitrillion-dollar firms and some of the market’s top-rated equities.
In fact, if you homed in on the best Nasdaq stocks at any given moment, you’d be looking at companies in some pretty rarified air. And you’d probably also be a little surprised.
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more – straight to your e-mail.
Profit and prosper with the best of expert advice – straight to your e-mail.
Although some of the Nasdaq’s best stocks are the mega caps that have carried the broader market for some time, others are lesser-known names that attract fewer headlines but are nonetheless swarming with bulls.
Nasdaq ascendant
Another massive initial public offering (IPO), another feather in the cap for the Nasdaq.
Recent years have seen it capture some of the biggest IPOs of all time, including Rivian Automotive (RIVN), Cerebras Systems (CBRS) and Arm Holdings (ARM).
In June, it landed the greatest lunker of them all: SpaceX (SPCX). At $75 billion raised, the SpaceX IPO was the largest offering ever.
And it’s not just new companies adding to the Nasdaq’s appeal. Many of the world’s largest stocks are already aligned with the stock exchange.
The Nasdaq has managed to lure numerous mega-cap NYSE listings, including tech-related names such as Palantir Technologies (PLTR) and DoorDash (DASH) and also consumer staples stocks like Walmart (WMT), Kimberly-Clark (KMB) and Campbell Soup (CPB).
In other words, while the Nasdaq is still heavily concentrated in tech stocks, tech-adjacent companies and biotechnology names, the exchange has more breadth than you might appreciate.
How I picked the best Nasdaq stocks
First things first, I needed to whittle the Nasdaq’s 4,000-plus equities to a more digestible universe.
To do that, I screened for stocks with the following characteristics.
- Trade on the Nasdaq Global Select Market, Nasdaq Global Market or Nasdaq Capital Market. These are three different tiers of the Nasdaq Stock Market covering large-cap stocks, mid-cap stocks and small-cap stocks, respectively.
- Have a market cap of at least $250 million. While I’m including large-, mid- and small-caps, I’m excluding micro- and nano-caps.
- Are incorporated in the United States. This is more for simplicity’s sake—companies that report in different currencies can provide false positives in certain screens.
- Meet a few basic financial-quality criteria. We include companies that grew earnings last year, are expected to grow earnings at least 5% annually on average over the next three to five years and have a debt-to-equity ratio of less than 1.5.
- Have a consensus Buy rating. All of the stocks have an average broker recommendation of 2.5 or lower within the ratings scale established by S&P Global Market Intelligence.e. Anything with a score of 2.5 or lower is considered a Buy.
- Have at least 10 covering analysts. This ensures there’s plenty of information and analysis available for these companies, and that consensus earnings estimates and ratings aren’t skewed by one or two professionals.
From there, I identified the five highest-rated stocks across five different sectors. I didn’t sacrifice quality to do so, either.
All five of the best Nasdaq stocks we talk about enjoy consensus “Strong Buy” ratings and fall within the 20 best-rated stocks on the entire exchange.
Data is as of June 14.
Amazon.com
(Image credit: Piotr Swat/SOPA Images/LightRocket)
- Sector: Consumer discretionary
- Market value: $2.6 trillion
- Dividend yield: N/A
- Consensus rating: 1.34 (Strong Buy)
Amazon’s businesses include its sprawling e-commerce empire, Amazon Web Services (AWS) cloud computing, Amazon Prime Video and Amazon Music streaming programming, Amazon Pharmacy, Kindle tablets, Echo smart speakers, Whole Foods grocery stores, Ring home security, Amazon MGM Studios production and distribution and so, so much more.
“We believe that AMZN merits a premium … given the company’s growth in high-end offerings such as Prime and Prime Video; superior growth in AWS, digital advertising, and subscription services; and unmatched volume and vendor leverage,” says Argus Research analyst Jim Kelleher, who has a Buy rating on the stock.
Amazon is also getting involved with artificial intelligence (AI) through its AWS unit. Its Bedrock service, for instance, helps developers build generative AI applications.
As Wedbush analyst Dan Ives notes, Amazon’s annual recurring revenue from AI has grown by approximately 260 times to more than $15 billion since Bedrock’s launch.
“While AWS AI continues to see incremental demand,” Ives writes, “customers are also leveraging AMZN’s non-AI services for multiple capabilities including compute, storage, databases, analytics, security amongst others with AWS being named a leader across all cohorts.”
Those are merely two of the 63 Buy calls on Amazon’s stock, making it one of the largest bull camps on Wall Street. The only remaining calls are a quartet of Holds; no one, at least at the moment, is willing to call AMZN a Sell.
And despite Amazon’s enormous size, at well more than $2 trillion in market cap, the pros still see the company generating robust average annual earnings growth of more than 20% over the next three to five years.
Meta Platforms
(Image credit: Samuel Boivin/NurPhoto)
- Sector: Communication services
- Market value: $1.4 trillion
- Dividend yield: 0.4%
- Consensus rating: 1.31 (Strong Buy)
Meta, like Amazon, is one of the most-covered stocks on the planet, and those analysts are similarly bullish: Fifty-eight Buys dramatically outweigh a mere six Holds and no Sells. Projected long-term earnings growth of more than 20% a year backs those optimistic calls.
Noting that Meta has relied on ads to drive a compound annual growth rate for revenue of approximately 45% over the last 15 years, Truist analyst Youssef Squali emphasizes management’s focus on building additional revenue sources so it can grow faster for longer. “These additional revenue sources are also meant to support the company’s massive capex investment in pursuit of AI superintelligence,” Squali observes.
But the communication services stock is down by double digits so far in 2026, most recently slipping on news that it also might be considering a multibillion-dollar sale of new shares to help finance those AI ambitions.
Indeed, META might represent the biggest question mark among the Nasdaq’s best stocks right now. Argus Research analyst Joseph Bonner, for instance, has a Buy rating on the stock, but he also shares numerous reasons for caution.
“The year 2026 may be a make-or-break time for Meta’s GenAI ambitions,” he says. “The company has spent for talent, and the commitment of CEO Mark Zuckerberg and the company as a whole is palpable. However, Meta has yet to deliver a truly breakthrough model and will probably need to do something at least close to a breakthrough this year to maintain credibility in the AI space.”
Allegro MicroSystems
(Image credit: Piotr Swat/SOPA Images/LightRocket)
- Sector: Information technology
- Market value: $9.3 billion
- Dividend yield: N/A
- Consensus rating: 1.25 (Strong Buy)
The Nasdaq’s best-rated names are expectedly thick in technology stocks broadly and semiconductor stocks specifically–many of them bigger, more broadly known and better-covered than the top-rated stock in the space.
Allegro MicroSystems (ALGM) is a chipmaker that specializes in sensing, motion control and power management in electromechanical and power conversion systems. And it’s increasingly focusing its efforts around four growth areas: advanced driver assistance systems (ADAS), robotics, electrification and industrial datacenters.
“The March-quarter print and June guide drive little change to numbers but reinforced the datacenter business as the most compelling growth pillar in the story,” says Jefferies analyst Blayne Curtis. “The segment reached a record ~14% of total company revenue in Q4 and is tracking to grow 20%+ sequentially again in the June quarter to 16%-17% of total company sales, representing one of the highest relative exposures of Analog companies in our coverage.”
Curtis also cites “one of the highest exposures to ADAS and xEV” in his bull thesis, and notes that while the automotive and industrial segments might have a little more weakness ahead, the company should “return to a [double-digit] revenue growth rate with increasing margins, given improving mix and efficiencies.”
UBS’s Timothy Arcuri says that after an in-line first-quarter report he still sees strong growth prospects and looks for fiscal 2027 and 2028 revenue growth in the mid-20s.
Jefferies and UBS aren’t alone in their upbeat views. All 12 of ALGM’s covering analysts call the stock a Buy, expecting the company to deliver 29% average annual bottom-line growth over the next three to five years.
Remitly Global
(Image credit: Cheng Xin/Getty Images)
- Sector: Financials*
- Market value: $4.0 billion
- Dividend yield: N/A
- Consensus rating: 1.20 (Strong Buy)
In 2025, it launched the Remitly One membership plan providing access to a host of products, including Remitly Flex, a no-interest “send now pay later” cash-advance product allowing for remittances up to $250; Remitly Wallet, a store-of-value product; Remitly Card, a digital debit card; and cash-back rewards. And it’s expected to launch a credit-building line of credit, Remitly Credit, this year.
RELY has been focused on expanding existing customer segments, too. June 2025 also saw the launch of Remitly for Business, a platform enabling businesses to pay employees, vendors and invoices that is predominantly focused on micro-businesses.
“Remitly has a small share of a massive, highly fragmented market; there are over 300 million immigrants and the global consumer-to-consumer cross-border payments market exceeds $2 trillion annually,” say William Blair analysts Cristopher Kennedy and Marc Feldman. “Market-share gains should be driven by expanding its presence into new geographic markets and by adding new users.”
Remitly’s stock has already climbed nearly 40% in 2026. However, Wall Street remains extremely bullish on the name, in part because of its potential long-term earnings growth, which analysts peg at 64% annually on average. All 10 covering analysts say RELY is a Buy, putting it among the Nasdaq’s best stocks right now.
* The Global Industry Classification Standard (GICS), which publishes S&P Dow Jones Indices like the S&P SmallCap 600, classifies Remitly as a financial company. However, other data providers, such as Morningstar, classify it as a technology firm.
BrightSpring Health Services
(Image credit: Thomas Fuller/SOPA Images/LightRocket)
- Sector: Healthcare
- Market value: $12.4 billion
- Dividend yield: N/A
- Consensus rating: 1.12 (Strong Buy)
The Nasdaq is known for hosting highflying biotech stocks whose novel treatments can trigger massive share spikes. However, the exchange’s top-rated healthcare stock, while highflying, has nothing to do with developing drugs in a lab.
BrightSpring Health Services (BTSG) is a home- and community-based healthcare services company. Its Pharmacy Solutions platform includes pharmaceutical care to long-term care and assisted living facilities, at-home pharmaceutical care to oncology patients and specialty infusion services.
Its Provider Services arm offers home health care, hospice services, behavioral health, neuro-rehabilitation, a variety of personal care services, and even family and youth services such as counseling and foster care.
Wall Street believes its adjusted bottom line will jump by 68% this year, and that long-term earnings growth will come in around 46% annually on average. A team of Morgan Stanley analysts says growth is being driven by “a consistent playbook—strong volume underpinned by execution and quality, efficiency gains from scale and disciplined M&A,” and management is applying it in large, underserved markets.
“Longer term,” they write, “BTSG sees meaningful runway across a diversified set of end markets—including Oncology, Infusion, Behavioral and Home & Community—while maintaining a dual focus on driving core growth within each segment and increasingly integrating capabilities (e.g., VBC, tech-enabled solutions) to unlock incremental value across the platform.”
Valuation has become a concern thanks to shares’ 70% year-to-date ascent, but the pros remain undeterred. All 17 covering analysts call BrightSpring a Buy.
“Shares trade at about 15.5 times our 2027 adjusted EBITDA estimate, toward the high end of healthcare services peers,” William Blair’s Jared Haase and Ryan Daniels wrote on June 3. “We believe the stock still presents an attractive risk/reward equation based on the growth momentum across the business and potential for further upside revisions to estimates.”
